Megan Bair, CNM
Advanced Practice Midwife · Upper Sandusky, OHNPI 1922490143
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 44 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 13.9% — the pattern of someone who eats at a lot of different presentations.
Across 44 payments — averaging $17.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$104
- Exeltis, USA Inc.$91
- Mayne Pharma Commercial LLC$90
- Sumitomo Pharma America, Inc.$74
- Aspira Women's Health Inc$47
- Novo Nordisk$44
- plus $298 from 13 others
What the payments were for
- Food & beverage$748100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 6 | $104 |
| Exeltis, USA Inc. | 6 | $91 |
| Mayne Pharma Commercial LLC | 4 | $90 |
| Sumitomo Pharma America, Inc. | 4 | $74 |
| Aspira Women's Health Inc | 3 | $47 |
| Novo Nordisk | 3 | $44 |
| Astellas Pharma US Inc | 2 | $35 |
| Lilly USA, LLC | 2 | $35 |
| Dexcom, Inc. | 2 | $33 |
| Bayer | 2 | $30 |
| Merck | 2 | $27 |
| Baxter Healthcare | 1 | $26 |
| Boston Scientific | 1 | $24 |
| Amgen | 1 | $18 |
| Mylan Pharmaceuticals Inc. | 1 | $17 |
| Biogen | 1 | $15 |
| Biomerieux Inc | 1 | $14 |
| Myovant Sciences Inc. | 1 | $12 |
| Organon | 1 | $12 |
How this compares
$748 in reported general payments places this provider in the 80th percentile of 300 advanced practice midwife providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 26 | $1,108 |
| Terconazole | 11 | $249 |
| LarinNorethindrone Ac/Eth Estradiol | 12 | $149 |
| Fluconazole | 16 | $75 |
Paid to pharmacies, not to this prescriber.
Other advanced practice midwife in Upper Sandusky
- Elizabeth NiedereggerCincinnati$76K
- Lucia JenkuskyColumbus$15K
- Hannah CackovicWorthington$12K
- Barbara FrancisPerrysburg$9K
- Rebecca Ulery TannerChillicothe$7K
- Sylvia SaikusCleveland$6K
- Chardina Murray-ManginoBoardman$3K
- Susan SommerOregon$3K
- Pamela MaddenEnglewood$3K
- Katherine BellomyWesterville$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.